UTILITY OF HEMOGLOBIN A1C TO IDENTIFY ED PTS WITHOUT PREVOUSLY DIAG DIABETES

这个子项目是许多研究子项目中的一个 由NIH/NCRR资助的中心赠款提供的资源。子项目及 研究者（PI）可能从另一个NIH来源获得了主要资金， 因此可以在其他CRISP条目中表示。所列机构为 研究中心，而研究中心不一定是研究者所在的机构。 艾德是糖尿病筛查的一种新的设置。我们试图评估未确诊糖尿病的艾德筛查。在MGH的一项初步研究中，我们将在6个数据采集日入组既往未诊断为糖尿病的成人艾德患者（约600例受试者）。 研究包括艾德访视、艾德POC HbA 1c和血糖以及门诊o-GTT（如果艾德筛选异常）。我们预计艾德患者中未确诊糖尿病的比例很高，并将利用这些初步数据计划一项艾德糖尿病筛查的多中心研究。

This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The ED is a novel setting for diabetes screening. We seek to evaluate ED screening for undiagnosed diabetes. In a pilot study at MGH, we will enroll adult ED patients without prior diagnosis of diabetes on 6 data collection days (~600 subjects). The study consists of ED interview, ED POC HbA1c and glucose, and outpatient o-GTT (if ED screening abnormal). We anticipate high rates of undiagnosed diabetes among ED patients and will use these preliminary data for planning a multicenter study of ED diabetes screening.